These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2548130)

  • 21. The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease.
    Gibb WR; Lees AJ
    Neuropathol Appl Neurobiol; 1989; 15(1):27-44. PubMed ID: 2542825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.
    Love S; Saitoh T; Quijada S; Cole GM; Terry RD
    J Neuropathol Exp Neurol; 1988 Jul; 47(4):393-405. PubMed ID: 2838588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Filaments of Lewy bodies contain insoluble cytoskeletal elements.
    Galloway PG; Mulvihill P; Perry G
    Am J Pathol; 1992 Apr; 140(4):809-22. PubMed ID: 1314025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanding the spectrum of neuronal pathology in multiple system atrophy.
    Cykowski MD; Coon EA; Powell SZ; Jenkins SM; Benarroch EE; Low PA; Schmeichel AM; Parisi JE
    Brain; 2015 Aug; 138(Pt 8):2293-309. PubMed ID: 25981961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ubiquitin and microtubule-associated protein tau immunoreactivity each define distinct structures with differing distributions and solubility properties in Alzheimer brain.
    Shaw G; Chau V
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2854-8. PubMed ID: 2833758
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathology of the cytoskeleton in Alzheimer's disease and disorders related to this disease].
    Seitelberg F; Lassmann H
    Gac Med Mex; 1990; 126(5):367-73. PubMed ID: 1966495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lewy-body formation is an aggresome-related process: a hypothesis.
    Olanow CW; Perl DP; DeMartino GN; McNaught KS
    Lancet Neurol; 2004 Aug; 3(8):496-503. PubMed ID: 15261611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunocytochemical and ultrastructural studies of lower motor neurons in amyotrophic lateral sclerosis.
    Murayama S; Mori H; Ihara Y; Bouldin TW; Suzuki K; Tomonaga M
    Ann Neurol; 1990 Feb; 27(2):137-48. PubMed ID: 2156479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aluminum-induced neuropathology: transient changes in microtubule-associated proteins.
    Muma NA; Singer SM
    Neurotoxicol Teratol; 1996; 18(6):679-90. PubMed ID: 8947945
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Filaments of Pick's bodies contain altered cytoskeletal elements.
    Perry G; Stewart D; Friedman R; Manetto V; Autilio-Gambetti L; Gambetti P
    Am J Pathol; 1987 Jun; 127(3):559-68. PubMed ID: 3296772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silver stainings distinguish Lewy bodies and glial cytoplasmic inclusions: comparison between Gallyas-Braak and Campbell-Switzer methods.
    Uchihara T; Nakamura A; Mochizuki Y; Hayashi M; Orimo S; Isozaki E; Mizutani T
    Acta Neuropathol; 2005 Sep; 110(3):255-60. PubMed ID: 16003542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitopes located in spatially separate domains of each neurofilament subunit are present in Parkinson's disease Lewy bodies.
    Hill WD; Lee VM; Hurtig HI; Murray JM; Trojanowski JQ
    J Comp Neurol; 1991 Jul; 309(1):150-60. PubMed ID: 1716646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Idiopathic Parkinsonism with Lewy-type inclusions in cerebral cortex. A case report.
    Ikeda K; Ikeda S; Yoshimura T; Kato H; Namba M
    Acta Neuropathol; 1978 Feb; 41(2):165-8. PubMed ID: 205083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigenic characteristics of neurofibrillary tangles in progressive supranuclear palsy.
    Galloway PG
    Neurosci Lett; 1988 Aug; 91(2):148-53. PubMed ID: 3185956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracytoplasmic inclusion bodies of the substantia nigra in myotonic dystrophy. Immunohistochemical observations.
    Ono S; Takahashi K; Fukuoka Y; Jinnai K; Kanda F; Kurisaki H; Mitake S; Inagaki T; Nagao K
    J Neurol Sci; 1997 May; 148(2):193-8. PubMed ID: 9129116
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and neuropathological correlates of Lewy body disease.
    Hishikawa N; Hashizume Y; Yoshida M; Sobue G
    Acta Neuropathol; 2003 Apr; 105(4):341-50. PubMed ID: 12624787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K; Hirai S; Sunohara N; Aoto K; Izumiyama Y; Uéda K; Ikeda K; Kawai M
    Brain Res; 1999 Oct; 843(1-2):53-61. PubMed ID: 10528110
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FBXO7 immunoreactivity in α-synuclein-containing inclusions in Parkinson disease and multiple system atrophy.
    Zhao T; Severijnen LA; van der Weiden M; Zheng PP; Oostra BA; Hukema RK; Willemsen R; Kros JM; Bonifati V
    J Neuropathol Exp Neurol; 2013 Jun; 72(6):482-8. PubMed ID: 23656991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ubiquitin-positive neuronal and tau 2-positive glial inclusions in frontotemporal dementia of motor neuron type.
    Forno LS; Langston JW; Herrick MK; Wilson JD; Murayama S
    Acta Neuropathol; 2002 Jun; 103(6):599-606. PubMed ID: 12012092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry.
    Lennox G; Lowe J; Landon M; Byrne EJ; Mayer RJ; Godwin-Austen RB
    J Neurol Neurosurg Psychiatry; 1989 Nov; 52(11):1236-47. PubMed ID: 2556498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.